Presentation
5 March 2021 Quantifying the photochemical damage potential of fluorescence contrast agents: singlet oxygen production
Author Affiliations +
Abstract
Recent advances in optical imaging have the potential to significantly improve patient outcomes. Among the most promising approaches under development is contrast-enhanced fluorescence imaging, which can be performed with molecular targeting to enhance tumor visualization. One key issue that has not been rigorously addressed is the potential phototoxicity of these fluorophores. In this study, we have used a commercial cell-free assay to qualify the singlet oxygen production rate in approved (ICG, Methylene Blue) and unapproved (IRDye700, IRDye800) fluorophores. Results shed light on the relative phototoxicity of each agent and will help to establish standardized methods for photochemical safety testing.
Conference Presentation
© (2021) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Brandon Gaitan, Rosalie Elespuru, Ellen Oskoui, Mariam Adwan, Anqi He, Huang-Chiao Huang, Yu Chen, and Joshua Pfefer "Quantifying the photochemical damage potential of fluorescence contrast agents: singlet oxygen production", Proc. SPIE 11660, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIII, 116600A (5 March 2021); https://doi.org/10.1117/12.2579521
Advertisement
Advertisement
KEYWORDS
Oxygen

Luminescence

Industrial chemicals

Molecules

Safety

Molecular imaging

Optical imaging

Back to Top